Towards defining a rigidity-associated pathogenic pathway in idiopathic parkinsonism.

R John Dobbs, André Charlett, Sylvia M Dobbs, Clive Weller, Owens Iguodala, Cori Smee, James Bowthorpe, David Taylor, Ingvar T Bjarnason

Journal: Neuro-degenerative diseases 2012;10(1-4):183-6

PMID: 22205039

Abstract

Helicobacter pylori eradication has a differential effect on the facets of idiopathic parkinsonism (IP): brady/hypokinesia improves, but rigidity worsens. Small intestinal bacterial overgrowth is common in IP and has been described as a sequel to Helicobacter eradication. The hyperhomocysteinaemia of IP is, in part, explained by serum vitamin B(12), but the concentration is not explained by Helicobacter status. Moreover, Helicobacter-associated gastric atrophy is uncommon in IP. However, overgrowth both increases B(12) utilization and provides a source of inflammation to drive homocysteine production. It is not a bystander event in IP: clouds of lysosomes are seen in duodenal enterocytes. Its candidature for causality of a rigidity-associated pathway is circumstantial: there are biological gradients of rigidity on natural killer and T-helper blood counts, both being higher with hydrogen breath test positivity for overgrowth.

Copyright © 2011 S. Karger AG, Basel.

Address: Institute of Pharmaceutical Sciences, King's College London, London, UK.

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.